← BICYCLE THERAPEUTICS PLC
| Annual Trend | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $2.1m |
$7.1m
+246.41%
|
$13.8m
+93.40%
|
$10.4m
-24.72%
|
$11.7m
+12.58%
|
$14.5m
+23.65%
|
$27.0m
+86.52%
|
$35.3m
+30.76%
|
$72.6m
+105.77%
|
$61.2m
-15.68%
|
|
| Net Interest Income | — | — | — | — | — | $2.4m |
$10.7m
+345.23%
|
$32.6m
+203.14%
|
$28.3m
-13.20%
|
$21.6m
-23.49%
|
|
| Research and development | $11.9m | $20.8m | $25.5m | $33.1m | $44.9m | $81.6m | $156.5m | $173.0m | $240.3m | $200.3m | |
| General and administrative | $6.4m | $8.1m | $14.6m | $29.2m | $32.4m | $49.5m | $60.4m | $72.2m | $79.4m | $71.5m | |
| Operating Expenses | $18.3m | $28.9m | $40.1m | $62.4m | $77.3m | $131.1m | $216.9m | $245.1m | $319.7m | $271.8m | |
| Loss from operations | ($16.2m) |
($21.7m)
-34.13%
|
($26.3m)
-20.94%
|
($52.0m)
-97.57%
|
($65.6m)
-26.29%
|
($116.7m)
-77.78%
|
($189.9m)
-62.83%
|
($209.9m)
-10.49%
|
($247.1m)
-17.72%
|
— | |
| Operating Income (Loss) | ($16.2m) |
($21.7m)
-34.13%
|
($26.3m)
-20.94%
|
($52.0m)
-97.57%
|
($65.6m)
-26.29%
|
($116.7m)
-77.78%
|
($189.9m)
-62.83%
|
($209.9m)
-10.49%
|
($247.1m)
-17.72%
|
($210.6m)
+14.77%
|
|
| Interest Income | $50k | $169k | $814k | $683k | $120k | $5.8m | $14.0m | $34.3m | $28.5m | $21.8m | |
| Net Non Operating Interest Income Expense | — | — | — | — | — | $2.4m | $10.7m | $32.6m | $28.3m | $21.6m | |
| Foreign Currency Transaction Gain (Loss), before Tax | — | — | — | — | — | ($600k) | ($600k) | ($700k) | $700k | — | |
| Foreign Currency Transaction Gain (Loss), Realized | — | $300k | $900k | $600k | $400k | — | — | — | — | — | |
| Gain On Sale Of Security | — | — | — | — | — | ($555k) | ($594k) | ($719k) | $653k | $283k | |
| Interest and Other Income | $50k | $169k | $814k | $683k | $120k | $5.8m | $14.0m | $34.3m | $28.5m | — | |
| Other Nonoperating Income (Expense) | — | ($665k) | ($5.4m) | — | — | — | — | — | — | — | |
| Interest Expense (non-operating) | — | — | — | $457k | $3.0m | $3.3m | $3.3m | $1.7m | $206k | $193k | |
| Other Income Expense | — | — | — | — | — | ($555k) | ($594k) | $2.8m | $653k | $283k | |
| Total other income, net | ($69k) | ($496k) | ($4.6m) | $226k | ($2.9m) | $2.4m | $10.7m | $36.1m | $28.3m | — | |
| Income (Loss) from Continuing Operations before Income Taxes, Domestic | — | ($13k) | $1.0m | $787k | $1.1m | $2.0m | $3.8m | $5.8m | ($225.5m) | ($188.7m) | |
| Pre-Tax Income | ($16.3m) | ($22.2m) | ($30.9m) | ($51.7m) | ($68.5m) | ($114.2m) | ($179.2m) | ($173.8m) | ($218.8m) | ($188.7m) | |
| Net loss before income tax provision | ($16.3m) | ($22.2m) | ($30.9m) | ($51.7m) | ($68.5m) | ($114.2m) | ($179.2m) | ($173.8m) | ($218.8m) | — | |
| Provision for (benefit from) income taxes | ($23k) | ($396k) | ($254k) | ($724k) | ($1.7m) | ($1.5m) | $1.5m | ($4.8m) | $152k | — | |
| Current Income Tax Expense (Benefit) | — | ($18k) | $110k | ($51k) | $5k | $3.5m | ($1.8m) | $461k | $1.0m | $1.7m | |
| Net loss | ($16.3m) | ($21.8m) | ($30.6m) | ($51.0m) | ($66.8m) | ($112.7m) | ($180.7m) | ($169.0m) | ($219.0m) | — | |
| Net Income From Continuing And Discontinued Operation | ($16.3m) | ($21.8m) | ($30.6m) | ($51.0m) | ($66.8m) | ($112.7m) | ($180.7m) | ($169.0m) | ($219.0m) | ($190.4m) | |
| Earnings Per Share, Basic | ($48.81) | ($49.78) | ($2.77) | ($2.66) | ($2.67) | ($3.80) | ($5.08) | ($2.90) | ($3.16) | ($2.73) | |
| Earnings Per Share, Diluted | ($48.81) | ($49.78) | ($2.77) | ($2.66) | ($2.67) | ($3.80) | ($5.08) | ($2.90) | ($3.16) | ($2.73) | |
| Common Stock, Dividends, Per Share, Declared | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | |
| Weighted Average Number of Shares Outstanding, Basic | — | — | 11.0m | 19.1m | 25.1m | 29.7m | 35.6m | 58.2m | 69.3m | 69.5m | |
| Weighted average ordinary shares outstanding, basic (in shares) | — | — | 11.0m | 19.1m | 25.1m | 29.7m | 35.6m | 58.2m | 69.3m | — | |
| Weighted average ordinary shares outstanding, diluted (in shares) | — | — | 11.0m | 19.1m | 25.1m | 29.7m | 35.6m | 58.2m | 69.3m | — | |
| Basic Average Shares | — | — | 11.0m | 19.1m | 25.1m | $29.7m | $35.6m | $58.2m | $69.3m | $69.5m | |
| Diluted Average Shares | — | — | 11.0m | 19.1m | 25.1m | $29.7m | $35.6m | $58.2m | $69.3m | $69.5m | |
| Weighted Average Number of Shares Outstanding, Diluted | — | — | 11.0m | 19.1m | 25.1m | 29.7m | 35.6m | 58.2m | 69.3m | 69.5m | |
| Additional Financial Items | |||||||||||
| Foreign currency translation adjustment | $2.4m | ($1.8m) | $216k | ($1.7m) | ($195k) | $3.8m | ($1.7m) | $1.4m | ($3.6m) | — | |
| Diluted EPS | ($48.81) | ($49.78) | ($2.77) | ($2.66) | ($2.67) | ($3.80) | ($5.08) | ($2.90) | ($3.16) | ($2.73) | |
| Diluted NI Availto Com Stockholders | ($16.3m) | ($21.8m) | ($30.6m) | ($51.0m) | ($66.8m) | ($112.7m) | ($180.7m) | ($169.0m) | ($219.0m) | ($190.4m) | |
| Normalized EBITDA | — | — | — | — | — | ($107.2m) | ($169.4m) | ($167.7m) | ($212.8m) | ($183.2m) | |
| Normalized Income | — | — | — | — | — | ($112.7m) | ($180.7m) | ($171.8m) | ($219.4m) | ($190.6m) | |
| Other Gand A | — | — | — | — | — | $49.5m | $60.4m | $29.3m | $30.2m | — | |
| Reconciled Depreciation | — | — | — | — | — | $3.7m | $6.5m | $7.2m | $6.4m | $5.3m | |
| Salaries And Wages | — | — | — | — | — | $30.3m | $35.9m | $42.2m | $49.8m | $46.2m | |
| Selling General And Administration | — | — | — | — | — | $49.5m | $60.4m | $71.5m | $80.0m | — | |
| Special Income Charges | — | — | — | — | — | $0 | $0 | $3.5m | $0 | $0 | |
| Tax Effect Of Unusual Items | — | — | — | — | — | $0 | $0 | $77k | $163k | $113k | |
| Tax Provision | ($23k) | ($396k) | ($254k) | ($724k) | ($1.7m) | ($1.5m) | $1.5m | ($4.8m) | $152k | $1.7m | |
| Tax Rate For Calcs | — | — | — | — | — | $0 | $0 | $0 | $0 | $0 | |
| Operating Expense | — | — | — | — | — | $131.1m | $216.9m | $244.4m | $320.3m | $271.8m | |
| Total comprehensive loss | ($13.9m) | ($23.7m) | ($30.4m) | ($52.7m) | ($67.0m) | ($108.9m) | ($182.4m) | ($167.6m) | ($222.6m) | — | |
| Total Unusual Items | — | — | — | — | — | $0 | $0 | $2.8m | $653k | $283k | |
| Total Expenses | — | — | — | — | — | $131.1m | $216.9m | $244.4m | $320.3m | $271.8m |